Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit

Annals of Thoracic Surgery

Volumn 72, Issue 2, 2001, Pages 521-526

  Ray, Michael J ^a   Hales, Majella M ^a   Brown, Lee ^a   O'Brien, Mark F ^a   Stafford, E Gregory ^a  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; D DIMER; PLACEBO;

ADULT; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BRAIN INFARCTION; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FIBRINOLYSIS; HEART VALVE SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; THORAX DRAINAGE;

6-AMINOCAPROIC ACID; AGED; APROTININ; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; CORONARY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; TREATMENT FAILURE;

EID: 0034898066     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(01)02819-3     Document Type: Article

References (17)

1. Bleeding hearts
2. Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass
3. Preoperative platelet dysfunction increases the benefit of aprofinin in cardiopulmonary bypass
4. Is epsilon-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery? A meta-analysis
5. Economic evaluation of high-dose and low-dose aprotinin therapy during cardiopulmonary bypass
6. Aprotinin for primary coronary artery bypass grafting: A multicenter trial of three dose regimens
7. Unorthodox use of aprotinin to control life-threatening bleeding after cardiopulmonary bypass
8. Aprotinin inhibits fibrinolysis, improves platelet adhesion and reduces blood loss. Results of a double-blind randomized clinical trial
9. Postoperative aprotinin: Effect on blood loss and transfusion requirements in cardiac operations
10. Epsilon-aminocaproic acid promotes the release of alpha2-antiplasmin during and after cardiopulmonary bypass
11. Low-dose aprotinin is ineffective to treat excessive bleeding after cardiopulmonary bypass
12. Aprotinin reduces blood loss after cardiopulmonary bypass by direct inhibition of plasmin
13. Aprotinin: Pharmacological reduction of perioperative bleeding
14. Troponin I, troponin T, or creatine kinase-MB to detect perioperative myocardial damage after coronary artery bypass surgery
15. Cardiac troponin I plasma levels for diagnosis, and quantitation of perioperative myocardial damage in patients undergoing coronary artery bypass surgery
16. A brief review of studies evaluating the adverse effects of aprotinin therapy in aortocoronary bypass surgery
17. Analyses of coronary graft patency after aprotinin use: Results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial